Verastem Oncology

Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on developing drugs to improve the survival and quality of life for cancer patients. Our portfolio includes small molecule kinase inhibitors that suppress key signaling pathways, promoting cancer cell survival and tumor growth.